PA News | PD Community News

The Parkinson Alliance is pleased to provide you with the latest news in our effort to finance research to help find the cause and cure of Parkinson's. 

PA News

The Parkinson Alliance Presented its New “Food, Wine, & Maybe Tuscany” Fundraiser on Saturday, November 4, 2017, in Princeton, NJ

The Parkinson Alliance Reports Survey Findings on Swallowing and Parkinson’s Disease From the Patient’s Perspective

The 18th Carnegie Center 5K and One-Mile Fun Run for The Parkinson Alliance Raised Over $100,000 in Support of Parkinson’s Disease Research

Bucks County Roadrunners Club Thanksgiving Day Race - Calling All Runners and Volunteers!

The Parkinson Alliance Announces That a New Fundraiser “Food, Wine, & Maybe Tuscany” Will Take Place on Saturday, November 4, 2017, in Princeton, NJ

The 18th Carnegie Center 5K and One-Mile Fun Run for The Parkinson Alliance Will Take Place on Saturday, September 23, 2017, in Princeton, NJ

The 23rd Parkinson’s Unity Walk Raised Over $1.5 Million in Donations for Parkinson's Disease Research

Participants Invited to Take Survey on Vision and Parkinson’s Disease

Acorda Submits New Drug Application to U.S. Food and Drug Administration for CVT-301

Team Parkinson Raised Over $113,000 at the 2017 Skechers Performance Los Angeles Marathon and LA BIG 5K in Support of Parkinson’s Disease Research

Survey Examines Social Support in Parkinson’s Disease from the Patient’s Perspective

Letter on Health Care Reform to President-Elect Trump from Patient Advocacy Organizations

Central Coast Follies Raises $33,000 for The Parkinson Alliance in Support of Research

The 2016 Carnegie Center 5K and Fun Run Breaks Fundraising Records with Over $110,000 Raised for The Parkinson Alliance

Survey Examines Patient Perceptions of Cognitive Changes in Parkinson’s Disease

New PD Exercise Program Offered at Fuse Fitness in Lawrenceville, NJ

Join Us at the World Parkinson Congress to Be Held on September 20-23, 2016 in Oregon

The Parkinson Alliance Announces That Gail Ruderman is the Recipient of the 2016 King Award

PD Community News

Nuplazid and Clozaril Are Most Reliable Parkinson’s Psychosis Therapies, Review Finds

NYU Langone Parkinson’s Program

Acorda Announces FDA Acceptance of New Drug Application for INBRIJA™

Act Now: Urge Congress to Fund a National Parkinson’s Database

NIH Scientists Adapt New Brain Disease Test for Parkinson’s, Dementia with Lewy Bodies

Sing for Parkinson’s Offered at Capital Health in Hopewell, NJ

Breakthrough Refinement of the Parkinson's Disease Exercise Prescription

Adamas Announces Publication of Amantadine Immediate Release Subgroup Analysis from EASE LID 2 Open-label Study

Brainstem Changes Identified in Parkinson’s Disease

Parkinson’s Protein Aggregates Seen in Action Destroying Neurons in Brain

Boston Scientific Receives U.S. FDA Approval for the Vercise™ Deep Brain Stimulation System

Study Shows That Parkinson's Disease Progression Can Be Slowed with Vigorous Exercise

Boston Scientific Receives U.S. FDA Approval for the Vercise™ Deep Brain Stimulation System

Acorda Resubmits NDA for Parkinson's Disease Candidate Inbrija

Acadia Launches Parkinson’s Campaign to Shine Light on Psychosis Symptoms

Low-Frequency Deep Brain Stimulation Found to Improve Cognition in Parkinson’s Disease Patients

Ultrasound Could Offer Noninvasive Treatment for Parkinson’s and Depression

Scientists Reveal Breakthrough in Brain Cell Repair Around Parkinson’s Disease

Veterans’ Coverage of Agent Orange-Related Diseases Delayed

OHSU Study Validates Deep Brain Surgery While Asleep for Parkinson's Patients

Insightec Gets FDA Blessing for Study of Exablate Neuro to Treat Parkinson’s Involuntary Movements

New UMass Lowell Study to Explore Link Between Gut Bacteria and Parkinson's Disease

Deep Sleep Linked to Cognitive Performance in People Living with Parkinson's

New Phase 3 Trial to Test Nuplazid for Parkinson’s Psychosis in Array of Dementia Patients

Scientists Identify the Structure of a Key Enzyme that Protects the Brain Against PD

First Patient Treated with Titan Pharmaceuticals' Subdermal Implant for Parkinson's Disease

Researchers Develop New Tool to Diagnose First Signs of Parkinson's Disease

MSU Researcher Hopes to Link Sense of Smell with Development of PD

Asthma Medication May Reduce the Risk of Developing Parkinson’s Disease

Adamas Announces FDA Approval of GOCOVRI™ as First and Only Medication for the Treatment of Dyskinesia in Parkinson’s Disease Patients

Telemedicine as Effective as In-person Care for Parkinson's Disease

Global Kinetics Corp Secures First US Patent for its Digital Health System

RWJ Medical School Will Host a Meeting on DBS for Parkinson’s Disease and Essential Tremor

PD Movement Lab’s “PD Outliers” Podcast with John Ball

LSVT Global Offers Free Educational Seminar for People with Parkinson’s Disease

Parkinson's Dance Program at Capital Health

Parkinson's Tai Chi Program at Capital Health

Diabetes Drug Shows Promise Against Parkinson’s Disease

The Michael J. Fox Foundation Announces Award to Drive Phase IIa Clinical Trial Investigating Potential Safety and Benefit of Nilotinib in PD

Forbes Includes Acadia, Maker of Nuplazid on List of Most Innovative Growth Companies

Mitsubishi Buys Israel's NeuroDerm for $1.1B

US WorldMeds is Now Distributing XADAGO® (Safinamide) in the U.S. for PD Patients

Drug Discovery: Alzheimer's and Parkinson's Spurred by Same Enzyme

Global Kinetics Launching Large Randomized Study of Wearable for Parkinson’s Disease

Study Suggests CLR01 May Improve Symptoms of Early Parkinson’s

Statins May Speed Symptoms of Onset Parkinson's Disease in Some People

Back to top